Vanda Pharmaceuticals | VNDA - Stock


Vanda Pharmaceuticals reported $1.85M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Acadia Pharmaceuticals USD 31.57M 3.1M Mar/2026
Agios Pharmaceuticals USD 35.09M 2.17M Mar/2026
Akebia Therapeutics USD 13M 2.61M Mar/2026
Alnylam Pharmaceuticals USD 200.15M 117.43M Mar/2026
Anika Therapeutics USD 22.84M 4.05M Mar/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
AstraZeneca USD 6.57B 13M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Eli Lilly USD 14.53B 785M Mar/2026
Esperion Therapeutics USD 104.21M 915K Mar/2026
Halozyme Therapeutics USD 155.47M 21.01M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 132.91M 841K Mar/2026
J&J USD 14.58B 392M Mar/2026
Lexicon Pharmaceuticals USD 276K 5K Mar/2026
Ligand Pharmaceuticals USD 13.27M 4.14M Mar/2026
Merck USD 6.48B 179M Mar/2026
Moderna USD 146M 7M Mar/2026
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 10.67B 13M Mar/2026
PTC Therapeutics USD 75.57M 4.08M Mar/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Takeda JPY 1.41T 107.71B Dec/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
Ultragenyx Pharmaceutical USD 55M 3M Mar/2026
Vanda Pharmaceuticals USD 1.85M 190K Dec/2025
Veracyte USD 21.42M 870K Mar/2026